Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by ikfe-CRO GmbH.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
ikfe-CRO GmbH
Boehringer Ingelheim
Information provided by (Responsible Party):
Marcus Borchert, ikfe-CRO GmbH
ClinicalTrials.gov Identifier:
NCT01547104
First received: February 21, 2012
Last updated: April 10, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)